Trevigen Releases Cell Line Producing a Critical Ingredient for 3-D Organoid Culture

press release

New Publication from the Trevigen Research Team: 

In Vitro Microtumors Provides a Physiologically Predictive Tool for Breast Cancer Therapeutic Screening 

Trevigen Awarded $1,500,000 Phase II SBIR Grant to Bring to Market the CometChip™: a Multi-Purpose High- Throughput Platform for DNA Damage and Repair Quantitation

press release